Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Teva Pharmaceutical Industries Ltd (NY: TEVA)
24.41 USD  +0.98 (+4.20%)
Streaming Delayed Price  /  Updated: 3:22 PM EDT, Sep 18, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 16,592,538
Open 23.29
Bid (Size) 24.41 (19)
Ask (Size) 24.42 (17)
Prev. Close 23.43
Today's Range 23.08 - 24.45
52wk Range 10.85 - 25.96
Shares Outstanding 1,018,482,488
Dividend Yield 4.87%
Performance
YTD
+27.76%
+27.76%
1 Month
-4.81%
-4.81%
3 Month
+0.81%
+0.81%
6 Month
+36.32%
+36.32%
1 Year
+43.70%
+43.70%
Top News
More News
Teva Announces Early Results of Debt Tender Offer and Election of Early Settlement
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the early tender results in connection with its previously announced tender offers (the “Offers”) to purchase for cash for a combined... Read More
from Business Wire News Releases
Teva Pharmaceutical Hits 80-Plus Relative Strength Rating Benchmark
Teva Pharmaceutical sees its Relative Strength Rating enter the 80-plus level. Read More
from Investor's Business Daily
More News
Read More
Teva Pops After Amgen-Rivaling Migraine Drug Gets FDA Approval
from Investor's Business Daily
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of M
from Business Wire News Releases
Credit Suisse Lifts Teva Price Target, Says Execution Is Key For Migraine Drug
category Analyst Ratings , Reiteration , Price Target , and 9 more.
from Benzinga
Mid-Afternoon Market Update: Dow Falls Over 50 Points; Select Income REIT Shares Spike Higher
category Mid/Afternoon Market Update , Markets , Eurozone , and 15 more.
from Benzinga
Does Ajovy's Approval Make Teva a Pain-Free Stock to Buy?
category AMGN , LLY , NVS , and 2 more.
from Motley Fool
Mid-Day Market Update: Senomyx Climbs Following Acquisition News; Government Properties Income Trust Shares Fall
category News , SNMX , SIR , and 16 more.
from Benzinga
EFV, TEVA, AER, CCE: Large Inflows Detected at ETF
category ETFs
from ETF Channel
Mid-Morning Market Update: Markets Mostly Lower; Teva's Preventive Migraine Treatment Approved By FDA
category Mid/Morning Market Update , News , EPM , and 16 more.
from Benzinga
10 Biggest Price Target Changes For Monday
category Information Technology , Price Target , MCHP , and 17 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.